Clinical Trial Update: Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SyB L-0501 for multiple myeloma was terminated. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• SyB L-0501

Snippet

Sponsor: SymBio Pharmaceuticals | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2013-03-18